Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.165 CAD -2.94%
Market Cap: 6.7m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Operating Margin
Innovotech Inc

-42.3%
Current
-5%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-42.3%
=
Operating Profit
-519.1k
/
Revenue
1.2m

Operating Margin Across Competitors

Country CA
Market Cap 6.6m CAD
Operating Margin
-42%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 200.7B USD
Operating Margin
17%
Country US
Market Cap 172.1B USD
Operating Margin
21%
Country KR
Market Cap 67.8T KRW
Operating Margin
31%
Country CH
Market Cap 38.6B CHF
Operating Margin
13%
Country US
Market Cap 38.8B USD
Operating Margin
25%
Country US
Market Cap 36.9B USD
Operating Margin
14%
Country US
Market Cap 26.9B USD
Operating Margin
28%
Country US
Market Cap 23.4B USD
Operating Margin
20%
Country US
Market Cap 23.2B USD
Operating Margin
29%
No Stocks Found

Innovotech Inc
Glance View

Market Cap
6.4m CAD
Industry
Life Sciences Tools & Services

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.068 CAD
Overvaluation 59%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-42.3%
=
Operating Profit
-519.1k
/
Revenue
1.2m
What is the Operating Margin of Innovotech Inc?

Based on Innovotech Inc's most recent financial statements, the company has Operating Margin of -42.3%.